Trinidad and To­ba­go has an­oth­er vac­cine in its ar­se­nal to fight the COVID-19 pan­dem­ic, fol­low­ing the World Health Or­ga­ni­za­tion (WHO) grant­i­ng Emer­gency Use List­ing (EUL) ap­proval for the Bharat BBV152 CO­V­AX­IN COVID-19 Vac­cine.

Health Min­is­ter Ter­rence Deyals­ingh has said that ad­di­tion­al pri­ma­ry vac­cine dos­es will be ad­min­is­tered to dif­fer­ent cat­e­gories of peo­ple who have al­ready re­ceived two shots.

The Min­istry of Health has re­vealed that 14 ad­di­tion­al peo­ple have suc­cumbed to COVID-19, mak­ing it 71 fa­tal­i­ties record­ed for the week to date.

CARPHA, the Caribbean Pub­lic Health Agency, will in­cor­po­rate whole genome se­quenc­ing (WGS) test­ing to de­tect COVID-19 (SARS-CoV-2) vari­ants, from Mon­day 15th No­vem­ber 2021, at the CARPHA Med­ical Mi­cro­bi­ol­o­gy Lab­o­ra­to­ry (CMML). 

“The chal­lenge to re­turn to nor­mal­cy is enor­mous as the an­ti-vaxxers in­ten­si­fy their cam­paigns.”

The coun­try's In­ten­sive Care Units for COVID-19 treat­ment have been threat­en­ing to over­flow for the past 16 days. But as of Wednes­day morn­ing, the ICUs in Trinidad are less oc­cu­pied than last week's peak.

(AP) — Vac­ci­na­tions fi­nal­ly are avail­able to U.S. chil­dren as young as 5, to the re­lief of some par­ents even as oth­ers have ques­tions or fears.

(AP) — The U.S. en­ters a new phase Wednes­day in its COVID-19 vac­ci­na­tion cam­paign, with shots now avail­able to mil­lions of el­e­men­tary-age chil­dren in what health of­fi­cials hailed as a ma­jor break­through af­ter more than 18 months of ill­ness, hos­pi­tal­iza­tions, deaths and dis­rupt­ed ed­u­ca­tion.

WASH­ING­TON (AP) — An­tic­i­pat­ing a green light from vac­cine ad­vis­ers, the Biden ad­min­is­tra­tion is as­sem­bling and ship­ping mil­lions of COVID-19 shots for chil­dren ages 5-11, the White House said Mon­day. The first could go in­to kids’ arms by mid­week.

"Nur­sie, I could video call my rel­a­tive?” a 26-year-old pa­tient asked as he lay at the In­ten­sive Care Unit (ICU) of the Cou­va Hos­pi­tal and Mul­ti-Train­ing Fa­cil­i­ty.

JAKAR­TA, In­done­sia (AP) — Biotech­nol­o­gy com­pa­ny No­vavax said Mon­day that In­done­sia has giv­en the world’s first emer­gency use au­tho­riza­tion for its COVID-19 vac­cine, which us­es a dif­fer­ent tech­nol­o­gy than cur­rent shots.

Ex­perts are track­ing a new mu­ta­tion of the Delta vari­ant of the coro­n­avirus re­port­ed in dozens of coun­tries…